Apr 19, 2025 8:48 am
In a recent study published in EClinicalMedicine, a team of scientists from the United States (U.S.) examined the longitudinal outcomes and clinical characteristics of coronavirus disease 2019 (COVID-19) vaccine-associated myocarditis or C-VAM and evaluated the risk of myocardial injury and cardiovascular outcomes due to C-VAM in the pediatric population and young adults.